Small Cap Decliners: Vital Therapies (NASDAQ:VTL), China Biologic Products (NASDAQ:CBPO), Versartis (NASDAQ:VSAR), Theravance (NASDAQ:TBPH), VASCO Data Security International(NASDAQ:VDSI)

Technology Stocks News 13

Vital Therapies currently has a Zacks Rank #3 (Hold). Vital Therapies Inc (NASDAQ:VTL) stock performance was -5.83% in last session and finished the day at $30.52. Traded volume was 94.00K shares in the last session and the average volume of the stock remained 96.31K shares.

China Biologic Products (CBPO) shares fell in late trading after the biopharmaceutical company said it plans to sell shares of its common stock in a public offering. China Biologic Products Inc (NASDAQ:CBPO) dropped -11.37 percent to $42.11 Wednesday on volume of 167.50K shares. The intra-day range of the stock was $41.63 to $46.17. China Biologic Products Inc (NASDAQ:CBPO) has a market capitalization of $987.17million.

Versartis (NASDAQ:VSAR) last issued its quarterly earnings data on Monday, May 5th. The company reported ($2.57) earnings per share for the quarter, beating the analysts’ consensus estimate of ($6.37) by $3.80. Analysts expect that Versartis will post $-11.18 EPS for the current fiscal year. Versartis Inc (NASDAQ:VSAR)’s stock on June 18, 2014 reported a decrease of -5.83% to the closing price of $28.25. Its fifty two weeks range is $23.51 -$36.86. The total market capitalization recorded $683.50million. The overall volume in the last trading session was 190.40K shares. In its share capital, VSAR has 24.19million outstanding shares.

Theravance, Inc. THRX-1.41%(“Theravance”) and Theravance Biopharma, Inc. on 2 June 2014 announced the completion of the separation of Theravance Biopharma, Inc., the research and development-based biopharmaceutical business, from Theravance, Inc. to form two, independent, publicly traded companies with differing business objectives and opportunities, via a dividend distribution of Theravance Biopharma shares to Theravance stockholders. On Wednesday, shares of Theravance Biopharma Inc (NASDAQ:TBPH) dropped -6.52% to close the day at $30.66. Company return on investment (ROI) is 919.40% and its monthly performance is recorded as 39.55%.

VASCO Data Security currently has a Zacks Rank #1 (Strong Buy). This provider of security software and services has seen one positive estimate revision in the last 60 days. The Zacks Consensus Estimate has also move higher over the same period. VASCO Data Security International, Inc. (NASDAQ:VDSI) stock performance was -6.15% in last session and finished the day at $11.97. Traded volume was million shares in the last session and the average volume of the stock remained 256.20K shares. The beta of the stock remained 1.79. VASCO Data Security International, Inc. (NASDAQ:VDSI) insider ownership is 1.70%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone